These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 10332535)

  • 1. Domperidone: a peripherally acting dopamine2-receptor antagonist.
    Barone JA
    Ann Pharmacother; 1999 Apr; 33(4):429-40. PubMed ID: 10332535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.
    Brown CK; Khanderia U
    Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domperidone: review of pharmacology and clinical applications in gastroenterology.
    Reddymasu SC; Soykan I; McCallum RW
    Am J Gastroenterol; 2007 Sep; 102(9):2036-45. PubMed ID: 17488253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domperidone, a new dopamine antagonist.
    Champion MC; Hartnett M; Yen M
    CMAJ; 1986 Sep; 135(5):457-61. PubMed ID: 3527396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Making a case for domperidone in the treatment of gastrointestinal motility disorders.
    Ahmad N; Keith-Ferris J; Gooden E; Abell T
    Curr Opin Pharmacol; 2006 Dec; 6(6):571-6. PubMed ID: 16997628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis.
    Patterson D; Abell T; Rothstein R; Koch K; Barnett J
    Am J Gastroenterol; 1999 May; 94(5):1230-4. PubMed ID: 10235199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacologic and clinical differentiation of prokinetic drugs].
    May B; Greving I
    Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domperidone in Parkinson's disease: a perilous arrhythmogenic or the gold standard?
    Lertxundi U; Domingo-Echaburu S; Soraluce A; García M; Ruiz-Osante B; Aguirre C
    Curr Drug Saf; 2013 Feb; 8(1):63-8. PubMed ID: 23656449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domperidone. A review of its use in diabetic gastropathy.
    Prakash A; Wagstaff AJ
    Drugs; 1998 Sep; 56(3):429-45. PubMed ID: 9777316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic.
    Brogden RN; Carmine AA; Heel RC; Speight TM; Avery GS
    Drugs; 1982 Nov; 24(5):360-400. PubMed ID: 6756878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisapride: a gastrointestinal prokinetic drug.
    Barone JA; Jessen LM; Colaizzi JL; Bierman RH
    Ann Pharmacother; 1994 Apr; 28(4):488-500. PubMed ID: 8038476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs in Focus: Domperidone.
    Puoti MG; Assa A; Benninga M; Broekaert IJ; Carpi FJM; Deganello Saccomani M; Dolinsek J; Homan M; Mas E; Miele E; Tzivinikos C; Thomson M; Borrelli O
    J Pediatr Gastroenterol Nutr; 2023 Aug; 77(2):e13-e22. PubMed ID: 37159421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.
    Wiseman LR; Faulds D
    Drugs; 1994 Jan; 47(1):116-52. PubMed ID: 7510617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current status of gastric prokinetic drugs.
    Schapira M; Henrion J; Heller FR
    Acta Gastroenterol Belg; 1990; 53(4):446-57. PubMed ID: 1982914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the current status of prokinetic agents in gastroenterology.
    McCallum RW
    Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine antagonists in the upper gastrointestinal tract.
    Valenzuela JE; Dooley CP
    Scand J Gastroenterol Suppl; 1984; 96():127-36. PubMed ID: 6382574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic gastroparesis. A critical reappraisal of new treatment strategies.
    Drenth JP; Engels LG
    Drugs; 1992 Oct; 44(4):537-53. PubMed ID: 1281070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domperidone is more effective than cisapride in children with diabetic gastroparesis.
    Franzese A; Borrelli O; Corrado G; Rea P; Di Nardo G; Grandinetti AL; Dito L; Cucchiara S
    Aliment Pharmacol Ther; 2002 May; 16(5):951-7. PubMed ID: 11966504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of gastrointestinal motility beyond metoclopramide and domperidone : Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders.
    Madisch A; Vinson BR; Abdel-Aziz H; Kelber O; Nieber K; Kraft K; Storr M
    Wien Med Wochenschr; 2017 May; 167(7-8):160-168. PubMed ID: 28424994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of diabetic gastroparesis.
    Mukhopadhyay P; Basu AK
    J Indian Med Assoc; 2005 Mar; 103(3):184, 186. PubMed ID: 16173296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.